# Trump admin funds ibogaine PTSD trials

> Trump administration allocates $4.9 million for ibogaine clinical trials to treat veteran PTSD.
- Title: Trump admin funds ibogaine PTSD trials · PhillyVoice
- Summary: Trump administration allocates $4.9 million for ibogaine clinical trials to treat veteran PTSD.
- Keywords: trump administration, ibogaine, ptsd, veterans, health and human services, robert f kennedy jr, joe rogan, fda, psychedelics, clinical trials, addiction, post traumatic stress disorder
- Source: PhillyVoice — https://phillyvoice.com/ibogaine-ptsd-addiction-trump
- Published: 2026-11-12T22:34:38.01+00:00
- Read time: 1 min
- Topics: trump administration, ibogaine, ptsd, veterans, health and human services, robert f kennedy jr, joe rogan, fda, psychedelics, clinical trials, addiction, post traumatic stress disorder
## Funding announcement
Trump administration announces $4.9 million for ibogaine clinical trials targeting veteran PTSD.
## Ibogaine background
Ibogaine, a psychoactive plant from Central and West Africa, is illegal in the U.S. and classified with LSD.
## 2024 study results
Small 2024 study showed ibogaine provides fast-acting relief for veteran PTSD but also linked to heart risks.
## Rogan influence
Podcaster Joe Rogan reportedly urged Trump administration to fund ibogaine research through direct communication.
## Health secretary statement
Health and Human Services Secretary Robert F. Kennedy Jr. said veterans described ibogaine as life-changing.
## Heart risks
Ibogaine has been linked to severe heart effects and deaths according to Rutgers Brain Health Institute.
## Previous support
Trump administration previously signed executive order to fast-track FDA approval for psychedelic mental health treatments.
## Treatment context
PTSD affects 7% of veterans and 6% of general population, with higher rates among female veterans.
## Current status
Ibogaine research remains limited due to U.S. classification as illegal psychedelic substance.
## Next steps
Administration aims to balance ibogaine's potential benefits with safety concerns for veterans.
## Key takeaway

Trump administration funds $4.9 million to research ibogaine for PTSD treatment in veterans.